
Please try another search
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is headquartered in Haifa, Israel.
Name | Age | Since | Title |
---|---|---|---|
Gil Shapira | 66 | 2012 | Non-Executive Director |
Joseph Rauch | 68 | 2012 | Executive Chairman of the Board |
Malcolm I. Hoenlein | 81 | - | Member of Business Advisory Board |
Ephraim Tzur | - | - | Member of Scientific Advisory Board |
Shai Meretzki | 56 | 2012 | Founder, CEO, President & Director |
Benjamin Shafir | 75 | 2020 | Independent Non-Executive Director |
Margalit Assayag | 61 | 2020 | Independent Non-Executive Director |
Nimrod Rozen | - | - | Member of Scientific Advisory Board |
Alon Ariel | 59 | 2020 | Non-Executive Director |
Edwin M. Horwitz | - | 2025 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review